Package 50268-143-15

Brand: bupropion hydrochloride

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 50268-143-15
Digits Only 5026814315
Product NDC 50268-143
Description

50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-143-15) / 1 TABLET, FILM COATED in 1 BLISTER PACK (50268-143-11)

Marketing

Marketing Status
Marketed Since 2017-08-02
Brand bupropion hydrochloride
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4b95b3fd-3945-41d9-e063-6294a90a34ed", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993687", "993691"], "spl_set_id": ["bcb4ef83-f272-4090-8547-9aaf4ab63667"], "manufacturer_name": ["AvPAK"]}, "finished": true, "packaging": [{"sample": false, "description": "50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-143-15)  / 1 TABLET, FILM COATED in 1 BLISTER PACK (50268-143-11)", "package_ndc": "50268-143-15", "marketing_start_date": "20170802"}], "brand_name": "Bupropion Hydrochloride", "product_id": "50268-143_4b95b3fd-3945-41d9-e063-6294a90a34ed", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "50268-143", "generic_name": "Bupropion Hydrochloride", "labeler_name": "AvPAK", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "100 mg/1"}], "application_number": "ANDA076143", "marketing_category": "ANDA", "marketing_start_date": "20170802", "listing_expiration_date": "20271231"}